Cargando…
Clinically meaningful benefit: real world use compared against the American and European guidelines
Autores principales: | Dreicer, Jessica J., Mailankody, Sham, Fakhrejahani, Farhad, Prasad, Vinay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802502/ https://www.ncbi.nlm.nih.gov/pubmed/29238046 http://dx.doi.org/10.1038/s41408-017-0009-8 |
Ejemplares similares
-
Thinking Systematically About the Off-Label Use of Cancer Drugs and Combinations for Patients Who Have Exhausted Proven Therapies
por: Mailankody, Sham, et al.
Publicado: (2016) -
Ethics of Clinical Trials in Low-Resource Settings: Lessons From Recent Trials in Cancer Medicine
por: Prasad, Vinay, et al.
Publicado: (2015) -
Frequency and level of evidence used in recommendations by the National Comprehensive Cancer Network guidelines beyond approvals of the US Food and Drug Administration: retrospective observational study
por: Wagner, Jeffrey, et al.
Publicado: (2018) -
Identifying “Real” Patients in the Real World
por: Callahan, Sean J.
Publicado: (2020) -
Real world and hyper reality
por: Gautret, Philippe, et al.
Publicado: (2021)